期刊文献+

甲状腺乳头状癌颈部Ⅴ区淋巴结转移危险因素分析 被引量:5

Predictors of level V lymphatic metastasis in papillary thyroid carcinoma
原文传递
导出
摘要 目的探讨甲状腺乳头状癌颈部V区淋巴结转移的预测因素,为确定甲状腺乳头状癌患者清扫V区淋巴结的指征寻找依据。方法回顾性分析2004年3月至2010年11月资料完整的122例甲状腺乳头状癌患者的临床病理资料。其中男性31例,女性91例;年龄8—87岁,中位年龄38.5岁。每个病例至少行一侧Ⅱ~Ⅵ区颈淋巴结清扫术,13例行Ⅰ-Ⅵ区颈淋巴结清扫术,19例行双侧颈淋巴结清扫术。用χ2检验对患者年龄、性别、术前远处转移、术后TNM分期、原发灶大小、癌灶多发、肿瘤浸润情况、中央区及同侧Ⅱ~Ⅳ区淋巴结转移情况与V区淋巴结转移进行单因素分析,用二分类Logistic回归对单因素分析中有统计学意义的指标进行多因素分析。结果甲状腺乳头状癌患者Ⅴ区淋巴结转移组与未转移组在年龄、性别、癌灶多发、中央区淋巴结转移、同侧Ⅱ区淋巴结转移、同侧Ⅲ区淋巴结转移及术后TNM分期等因素比较中差异无统计学意义(χ2=0.882~3.167,P〉0.05),而在肿瘤浸润被膜、浸润甲状腺外组织、术前远处转移、原发灶〉4.0cm、同侧Ⅳ区淋巴结转移及同侧Ⅱ、Ⅲ、Ⅳ区淋巴结同时转移等因素中差异有统计学意义(χ2=4.223—13.748,P〈0.05)。多因素分析显示,肿瘤浸润甲状腺外组织(OR=8.32,95%CI:2.44~28.3,P=0.001)和同侧Ⅱ、Ⅲ、Ⅳ区淋巴结同时转移(OR:7.81,95%CI:2.11—28.8,P=0.002)是Ⅴ区淋巴结转移的高危因素。结论肿瘤浸润甲状腺外组织及同侧Ⅱ、Ⅲ、Ⅳ区淋巴结同时转移是甲状腺乳头状癌患者Ⅴ区淋巴结转移的危险因素,对于这一类患者建议行Ⅴ区淋巴结清扫。 Objective To study the predictors of level V metastasis in papillary thyroid carcinoma (PTC). Methods The clinic data of 122 patients with PTC who underwent therapeutic lateral neck dissection between March 2004 and November 2010 was analyzed retrospectively. There were 31 male and 91 female patients. The median age at diagnosis was 38.5 years (ranging from 8 to 87 years). All the patients had undergone unilateral or bilateral lymph node dissection ( II -VI or I -VI ). Univariate analysis and multivariate analysis were performed using X2 test and binary Logistic regression test, respectively. Result The level V metastases was significantly associated with capsular invasion, extrathyroidal extension, preoperative distant metastasis, the size of primary, ipsilateral level IV lymph node metastasis and simultaneous metastases to ipsilateral level II ,III and IV ( X2 = 4. 223-13. 748, P 〈 0.05 ). Age, sex, tumor-muhifocal, pTNM, central lymph node metastases ipsilateral level II lymph node metastases and ipsilateral level II1 lymph node metastases were not found to be associated with level V metastases (χ2 = 0. 882-3. 167, P 〉0. 05 ). In multivariate analysis, extrathyroidal extension ( OR = 8.32, 95% CI: 2.44- 28.3, P =0. 001 ) and simultaneous metastases to ipsilateral level II , Ill and IV ( OR = 7.81, 95% CI: 2. 11-28.8, P = 0. 002) were independent predictors of level V metastasis. Conclusions Extrathyroidal extension, simultaneous metastases to ipsilateral level IT , III and IV are risk factors for level V lymph nodes metastases in PTC. Dissection of level V lymph nodes should be considered for PTC patients with extrathyroidal extension and simultaneous metastases to ipsilateral level II , III and IV.
出处 《中华外科杂志》 CAS CSCD 北大核心 2012年第7期625-628,共4页 Chinese Journal of Surgery
关键词 甲状腺肿瘤 乳头状 淋巴转移 颈淋巴结清扫术 危险因素 Thyroid neoplasms Carcinoma, papillary Lymphatic metastasis Neck dissection Risk factors
作者简介 通信作者:朱精强,Email:zjqwkys@hotmail.com
  • 相关文献

参考文献16

  • 1Grebe SK, Hay ID. Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am, 1996,5:43-63.
  • 2Mazzaferri EL. Management of a solitary thyroid nodule. N Eng J Med, 1993,328:553-559.
  • 3Scheumann GF, Gimm O, Wegener G, et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid-cancer. World J Surg, 1994,18:559-567.
  • 4王圣应,朱正志,彭德峰,王东风.分化型甲状腺癌颈淋巴结转移规律的研究[J].中华外科杂志,2008,46(18):1404-1406. 被引量:17
  • 5Caron NR, Tan YY, Ogilvie JB, et al. Selective modified radical neck dissection for papillary thyroid cancer-is level I , II and V dissection always necessary? World J Surg,2006,30:833-840.
  • 6Gimm O, Rath FW,Dralle H. Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg, 1998,85:252-254.
  • 7Roh JL, Park JY, Park CI. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg,2007 ,245 :604-610.
  • 8Machens A, Hinze R, Thomusch O, et al. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg,2002 ,26 :22-28.
  • 9Yanir Y, Doweck I. Regional metastases in well-differentiated thyroid carcinoma: pattern of spread. Laryngoscope, 2005, 118: 433-436.
  • 10Robbins KT, Clayman G, Levine PA, et al. Neck dissection classification update:revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg,2002,128: 751-758.

二级参考文献27

  • 1陈辉,赵敏,陈贤明,王茂鑫,王喻,许素媛.彩超在诊断分化型甲状腺癌颈淋巴结转移中的应用[J].中国耳鼻咽喉头颈外科,2006,13(4):211-214. 被引量:29
  • 2Kouvaraki MA, Shapiro SE, Fomage BD, et al. Role of preoperative uhrasonography in the surgical management of patients with thyroid cancer. Surgery ,2003,134:946-954.
  • 3Kinder BK. Well differentiated thyroid cancer. Curr Opin Oncol, 2003,15:71-77.
  • 4Mazzaferri EL, Massoll N. Management of papillary and follicular (differentiated) thyroid cancer:new paradigms using recombinant human thyrotropin. Endocr Relat Cancer,2002,9:227-247.
  • 5Simon D, Goretzki PE, Witte J, et al. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg, 1996,20:860-866.
  • 6Mazzaferri EL,Kloos RT. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab ,2001,86 : 1447-1463.
  • 7Noguchi S, Murakami N, Yamashita H, et al. Papillary thyroid carcinoma:modified radical neck dissection improves prognosis. Arch Surg, 1998,133:276-280.
  • 8Kupferman ME, Patterson M, Mandel S J, et al. Patterns of lateral neck metastasis in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg,2004,130 : 857-860.
  • 9Caron NR,Tan YY, Ogilvie JB, et al. Selective modified radical neck dissection for papillary thyroid cancer - is level Ⅰ , Ⅱ and Ⅴ dissection always necessary? World J Surg,2006,30:833-840.
  • 10Kupferman ME, Weinstock YE, Santillan AA, et al. Predictors of level V metastasis in well-differentiated thyroid cancer. Head Neck ,2008,30 : 1469-1474.

共引文献19

同被引文献66

  • 1赏金标,王可敬,张海,刘爱华,郭良,葛明华.甲状腺乳头状癌再次手术临床分析[J].中华普通外科杂志,2005,20(2):123-123. 被引量:19
  • 2Ito Y,Higashiyama T,Takamura Y,et al. Risk factors for recurence to the lymph node in papillary thyroid carcino- ma patients without preoperatively detectable lateral node metastasis:validity of prophylactic modified radical neck dissection[J]. World J Surg, 2007,31 (11) : 2085-2091.
  • 3Vergez S,Sarini J,Percodani J,et al. Lymph node manage- ment in clinically node-negative patients with papillary thy- roid carcinoma[J]. Eur J Surg Oncol, 2010,36(8) : 777-782.
  • 4Patron V,Bedfert C,Le Clech G,et al. Pattern of lateral neck metastases in NO papillary thyroid carcinoma [J]. BMC Cancer, 2011,11 : 8.
  • 5Dionigi G, Dionigi R, Bartalena L, et al. Surgery of lymph node in papillary thyroid cancer[J]. Expert Rev Anticancer Ther, 2006,6(9) .. 1217-1229.
  • 6Wada N,Suganuma N,Nakayama H,et al. Microscopic re- gional lymph node status in papillary thyroid carcinoma with and without lymphadenopathy and its relation to out- comes[J]. Langenbecks Arch Surg, 2007,392(4) :417-422.
  • 7Cooper DS,Doherty GM,Haugen BR,et al. Revised Ameri- can Thyroid Association Management Guidelines for pa- tients with thyroid nodules and differentiated thyroid can- cer[J]. Thyroid, 2009,19(11): 1167-1214.
  • 8Farrag T, Lin F, Brownlee N, et al. ls routine dissection of level II-B and V-A necessary in patients with papillary thyroid cancer undergoing lateral neck dissection for FNA- confirmed metastases in other levels[J]. World J Surg, 2009, 33(8): 1680-1683.
  • 9Park JY, Koo BS. Individualized optimal surgical extent of the lateral neck in papillary thyroid cancer with lateral cervical metastasis[J]. Eur Arch Otorhinolaryngol,2014, 271(6) : 1355-1360.
  • 10Pingpank JF,Sasson AR,Hanlon AL,et al. Tumor above the spinal accessory nerve in papillary thyroid cancer that involves lateral neck nodes:a common occurrence[J]. Arch Otolaryngol Head Neck Surg,2002,128(11) : 1275-1278.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部